학술논문
Tumor shrinkage and increased overall survival are associated with improved albumin, neutrophil lymphocyte ratio (NLR) and decreased durvalumab clearance in NSCLC and UC patients receiving durvalumab.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755